CIAM
AQST icon

Caitong International Asset Management’s Aquestive Therapeutics AQST Stock Holding History

Caitong International Asset Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
+3,321
New +$14K ﹤0.01% 1077
2026
Q1 		– Sell
-6,289
Closed -$40.6K – 2589
2025
Q4 		$40.6K Buy
6,289
+2,269
+56% +$14.1K 0.01% 785
2025
Q3 		$22.5K Buy
4,020
+901
+29% +$3.9K 0.02% 647
2025
Q2 		$10.3K Buy
3,119
+2,439
+359% +$7K 0.01% 712
2025
Q1 		$1.97K Buy
+680
New +$2.06K ﹤0.01% 1353

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Caitong International Asset Management's AQST Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 3,321 shares worth $13.8K. The stake represents ﹤0.01% of the portfolio and ranks #1077 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in AQST as recently as Q4 2025.

Caitong International Asset Management first reported a position in AQST in Q1 2025 and has held it in 5 quarters since. The position peaked at $40.6K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Caitong International Asset Management held 3,321 shares of Aquestive Therapeutics worth $13.8K as of Q2 2026.
  • Aquestive Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1077 holding.
  • Caitong International Asset Management first reported a position in Aquestive Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Aquestive Therapeutics position peaked at $40.6K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.